Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.70% | -17.06% | 222.49% | -53.99% | -31.78% |
| Total Depreciation and Amortization | -0.82% | 3.39% | 189.17% | -202.58% | 1.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,338.64% | 109.87% | -29.28% | -211.65% | 107.38% |
| Change in Net Operating Assets | 110.00% | -98.50% | 607.63% | 30.13% | -244.04% |
| Cash from Operations | -33.77% | -55.84% | 5,057.14% | -92.60% | -44.74% |
| Capital Expenditure | 6.97% | -22.13% | 19.80% | 18.61% | -34.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -84.85% | 3,200.00% | -98.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -484.98% | 131.59% | -295.03% | 183.70% | -84.04% |
| Cash from Investing | -1,349.69% | 109.68% | -453.88% | 137.91% | -78.17% |
| Total Debt Issued | 572.86% | -106.75% | -33.40% | -56.02% | 1,256.32% |
| Total Debt Repaid | 238.29% | 58.38% | -278.60% | 73.82% | -1,981.82% |
| Issuance of Common Stock | -3.85% | -29.73% | -36.21% | -- | -- |
| Repurchase of Common Stock | -40.85% | 79.71% | -145.34% | 45.56% | -191.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.80% | 0.27% | 1.05% | 1.04% |
| Other Financing Activities | -58.33% | 500.00% | -125.00% | -42.86% | 600.00% |
| Cash from Financing | 156.09% | 40.60% | -1,165.68% | -2.88% | 178.90% |
| Foreign Exchange rate Adjustments | 33.33% | 66.67% | -50.00% | -500.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.83% | 246.39% | -78.66% | 408.50% | -85.57% |